Savara (SVRA) Net Income (2010 - 2026)

Savara (SVRA) reported Net Income of -$37.9 million for Q1 2026, down 42.4% year-over-year from -$65.9 million in Q1 2025, and down 17.72% quarter-over-quarter from -$32.2 million in Q4 2025.

Savara (SVRA) Net Income (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Net Income data on file, last reported at -$37.9 million in Q1 2026.

  • Net Income for Q1 2026 came in at -$37.9 million, down 42.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$130.4 million (down 27.52% YoY), and the FY2025 annual result was -$119.4 million, down 23.42% from the prior year.
  • Net Income declined to -$37.9 million in Q1 2026 per SVRA's latest filing, from -$32.2 million in the prior quarter.
  • Over five years, Net Income peaked at -$8.6 million in Q1 2022 and troughed at -$37.9 million in Q1 2026.
  • A 5-year average of -$20.4 million and a median of -$20.3 million in 2024 frame the typical range for Net Income.
  • The sharpest annual moves came in 2022 and 2024: Net Income climbed 21.72% in 2022, then sank 92.13% in 2024.
  • A 5-year view of Net Income shows it stood at -$10.3 million in 2022, then plunged by 57.01% to -$16.1 million in 2023, then sank by 81.62% to -$29.3 million in 2024, then declined by 10.13% to -$32.2 million in 2025, then retreated by 17.72% to -$37.9 million in 2026.
  • Business Quant data shows SVRA's Net Income at -$37.9 million in Q1 2026, -$32.2 million in Q4 2025, and -$29.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Savara 1.39 Bn 1.39 Bn - -37.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -37.93 Mn
Dec 31, 2025 -32.22 Mn
Sep 30, 2025 -29.71 Mn
Jun 30, 2025 -30.52 Mn
Mar 31, 2025 -26.64 Mn
Dec 31, 2024 -29.26 Mn
Sep 30, 2024 -24.23 Mn
Jun 30, 2024 -22.12 Mn
Mar 31, 2024 -20.35 Mn
Dec 31, 2023 -16.11 Mn
Sep 30, 2023 -16.60 Mn
Jun 30, 2023 -11.51 Mn
Mar 31, 2023 -11.35 Mn
Dec 31, 2022 -10.26 Mn
Sep 30, 2022 -10.38 Mn
Jun 30, 2022 -9.67 Mn
Mar 31, 2022 -8.62 Mn
Dec 31, 2021 -11.20 Mn
Sep 30, 2021 -10.54 Mn
Jun 30, 2021 -11.01 Mn